CYBB and chronic granulomatous disease: Another evidence for the role of Nox2-ROS signaling in the mobilization of HSPCs is data from patients with chronic granulomatous disease (CGD) in which either Nox2 deficiency or mutations in the NADPH oxidase complex subunits render them poor mobilizers [20].